Monday, July 8, 2019

SPARC gets orphan drug designation from USFDA for novel kinase inhibitor

SPARC gets orphan drug designation from USFDA for novel kinase inhibitor The Orphan Drug Act provides economic incentives to encourage the development of drugs for diseases affecting fewer than 2 lakh people in the US, Sun Pharma Advanced Research Company (SPARC) said in a filing to BSE.

from Moneycontrol Business News https://ift.tt/2L8Hplf
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

All bad news is priced in, but don't call it a bull market yet: SAMCO MF CEO Viraj Gandhi

Largecaps offer better safety as valuations are below historical averages. Private banks and cement sectors show clear earnings visibility a...